Treatment Strategy for Combined Carotid Artery Stenosis and Coronary Artery Disease: Staged or Simultaneous Surgical Procedure?

Yuan, Shi-Min; Wu, Hai-Wei; Jing, Hua
November 2009
Tohoku Journal of Experimental Medicine;Nov2009, Vol. 219 Issue 3, p243
Academic Journal
Patients with combine carotid and coronary arterial disease pose a high risk of cerebrovascular events, and the treatment of choice with either a simultaneous or a staged surgical procedure remains controversial. The literature of combined carotid and coronary simultaneous or staged carotid and coronary procedures from 53 reports were included. As a result, carotid endarterectomy plus coronary artery bypass remained the most commonly used procedure for the intervention of combined carotid artery stenosis and coronary artery disease, and was associated with higher incidences of perioperative transient ischemic attack, stroke and hospital mortality, but with less perioperative myocardial infarction comparing with the staged procedures. Patients with a simultaneous carotid endarterectomy and coronary artery bypass were generally related more to an advanced atherosclerotic coronary artery disease, so that a pure comparison between the two strategies was not always possible. To compare the efficacy of different surgical methods for combined carotid and coronary arterial diseases is of pronounced importance. The new hybrid approach consisting of the simultaneous carotid artery stenting and subsequent on-pump coronary artery bypass can be a safe approach, with the aim to reduce the surgical trauma as compared to surgical procedures, and to reduce the risk of myocardial infarction in the interval period required for the staged operations. Thus, for patients with combined carotid artery stenosis and coronary artery disease, the simultaneous surgical procedure, rather that the staged procedure, is recommended.


Related Articles

  • Risk Factors Associated with Recurrent Carotid Artery Stenosis. Liapis, Christos D.; Kakisis, John D.; Papavassiliou, Vassilios G.; Koumakis, Konstantinos M.; Gogas, John G. // Vascular Surgery;Nov/Dec1999, Vol. 33 Issue 6, p697 

    The aim of this open, perspective study was to determine the impact of risk factors, excluding the type of closure of the arteriotomy, in the development of recurrent carotid stenosis following carotid endarterectomy. One hundred and ninety-eight patients, who underwent a total of 221 carotid...

  • Coronary heart disease in China. Zhang, X-H.; Lu, Z. L.; Liu, L. // Heart;Sep2008, Vol. 94 Issue 9, p1126 

    Coronary heart disease (CHD) is the second leading cause of cardiovascular death in the Chinese population. It accounts for 22% of cardiovascular deaths in urban areas and 13% in rural areas. Although mortality from CHD in China is relatively low compared with Western levels, the burden of CHD...

  • Population Assessment of Future Trajectories in Coronary Heart Disease Mortality. Thorolfsdottir, Rosa Björk; Aspelund, Thor; Capewell, Simon; Critchley, Julia; Gudnason, Vilmundur; Andersen, Karl // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s, largely reflecting improvements in cardiovascular risk factors. The purpose of this study was to predict future CHD mortality in Iceland based on potential risk factor trends. Methods and...

  • Impact of a Partial Smoke-Free Legislation on Myocardial Infarction Incidence, Mortality and Case-Fatality in a Population-Based Registry: The REGICOR Study. Agüero, Fernando; De´gano., Irene R.; Subirana, Isaac; Grau, Maria; Zamora, Alberto; Sala, Joan; Ramos, Rafel; Treserras, Ricard; Marrugat, Jaume; Elosua, Roberto // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background and Objective: Coronary heart disease (CHD) is the leading cause of death, and smoking its strongest modifiable risk factor. Our aim was to determine the impact of the Spanish 2006 partial smoke-free legislation on acute myocardial infarction (AMI) incidence, hospitalization and...

  • A Study of Coronary Heart Disease in Postmenopausal Women and Identification of Major Modifiable Determinant Risks for its Prevention. Pradhan, P.; Upadhya, A. V. // Journal of the South Asian Federation of Menopause Societies;Jul-Dec2013, Vol. 1 Issue 2, p56 

    This is a retrospective study of postmenopausal women admitted with myocardial infarction (MI) in five hospitals (Nepal Medical College, Bir Hospital, Institute of Medicine, Norvic International Hospital, Medicare Hospital) having coronary care unit (CCU) in Kathmandu, Nepal, in 1 year period,...

  • Analysis of cost-effectiveness of antidyslipidemic therapy for preventing myocardial infarction... Haynes, R. Brian // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p22 

    Discusses the use of antidyslipidemic therapy for the prevention of myocardial infarction (MI) and death in the United States. Debate over the effects of lowering elevated lipids; Individual baseline risk; Risk of subsequent cardiovascular events after MI.

  • Serum Urate Predicts Long-Term Risk of Acute Coronary Events in Women after a Transient Ischaemic Attack and Stroke. Koton, Silvia; Howard, Sally C.; Warlow, Charles P.; Murphy, Michael F. G.; Rothwell, Peter M. // Cerebrovascular Diseases;Nov2008, Vol. 26 Issue 5, p517 

    Background: Several studies have shown serum urate to be an independent risk factor for vascular disease, but others have not, although a stronger association in women than in men has been a consistent finding. Studies of stroke patients have shown possible associations between urate level and...

  • Primary prevention is strategy of choice and population based prevention needs more emphasis - Dr. Abu Baker Sheikh.  // Pulse International;8/31/2014, Vol. 15 Issue 16, p4 

    The article discusses the highlights of the second scientific session of the 5th Preventive Cardiology Conference that was held in Quetta, Pakistan from August 9-10, 2014. Topics discussed include the prevention of coronary artery disease (CAD) in women, the presence of cardiovascular risk...

  • Guide to comprehensive risk reduction for patients with coronary and other vascular disease.  // American Family Physician;10/1/1995, Vol. 52 Issue 5, p1578 

    Lists recommendations for risk interventions in the prevention of coronary heart disease and other vascular diseases. Risk interventions include smoking cessation; Lipid management; Increasing physical activity; Weight management; Use of antiplatelet agents and anticoagulants;...

  • Favorite things. the heart truth. Brechka, Nicole // Better Nutrition;Mar2012, Vol. 74 Issue 3, p72 

    The article presents an interview with physician and author Mark C. Houston. When asked why he wanted to write the book "What Your Doctor May Not Tell You About Heart Disease", Houston says that there are several hundred risk factors for heart disease that aren't being evaluated or treated. He...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics